Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.

BACKGROUND: Geriatric depression with subjective cognitive complaints increases the risk of Alzheimer’s Disease (AD). Memantine is a cognitive enhancer used to treat AD. In a 6-month double-blind randomized placebo-controlled trial of escitalopram and memantine (ESC/MEM), ESC/MEM improved cognition...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Affect Disord
Asıl Yazarlar: Krause-Sorio, Beatrix, Siddarth, Prabha, Kilpatrick, Lisa, Laird, Kelsey T., Milillo, Michaela M., Ercoli, Linda, Narr, Katherine L., Lavretsky, Helen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368564/
https://ncbi.nlm.nih.gov/pubmed/32663977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2020.05.092
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller